Annual CFF
$1.41 M
+$1.44 M+4095.17%
December 31, 2023
Summary
- As of February 7, 2025, MEDS annual cash flow from financing activities is $1.41 million, with the most recent change of +$1.44 million (+4095.17%) on December 31, 2023.
- During the last 3 years, MEDS annual CFF has fallen by -$3.89 million (-73.47%).
Performance
MEDS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$1.87 M
-$1.87 M-100.00%
September 30, 2024
Summary
- As of February 7, 2025, MEDS quarterly cash flow from financing activities is -$1.87 million, with the most recent change of -$1.87 million (-100.00%) on September 30, 2024.
- Over the past year, MEDS quarterly CFF has increased by +$12.02 million (+86.52%).
Performance
MEDS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$14.43 M
-$1.99 M-15.98%
September 30, 2024
Summary
- As of February 7, 2025, MEDS TTM cash flow from financing activities is -$14.43 million, with the most recent change of -$1.99 million (-15.98%) on September 30, 2024.
- Over the past year, MEDS TTM CFF has dropped by -$1.26 million (-9.59%).
Performance
MEDS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MEDS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4095.2% | +86.5% | -9.6% |
| 3 y3 years | -73.5% | -792.3% | -6879.9% |
| 5 y5 years | +107.6% | -177.6% | -758.3% |
MEDS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -114.8% | -240.3% | +641.6% | -1126.3% | at low |
| 5 y | 5-year | -73.5% | -114.8% | -135.6% | +641.6% | -293.0% | at low |
| alltime | all time | -94.8% | -114.8% | -106.9% | +641.6% | -153.3% | at low |
TRxADE HEALTH Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.87 M(<-9900.0%) | -$14.43 M(+16.0%) |
| Jun 2024 | - | $0.00(-100.0%) | -$12.45 M(-5.5%) |
| Mar 2024 | - | -$13.90 M(-1140.6%) | -$13.17 M(-1036.5%) |
| Dec 2023 | $1.41 M(-4095.2%) | $1.34 M(+1061.2%) | $1.41 M(-705.7%) |
| Sep 2023 | - | $115.00 K(-115.9%) | -$232.20 K(-34.6%) |
| Jun 2023 | - | -$725.30 K(-206.5%) | -$355.10 K(-138.6%) |
| Mar 2023 | - | $681.30 K(-324.7%) | $920.20 K(-2714.2%) |
| Dec 2022 | -$35.20 K(-83.1%) | -$303.20 K(+3738.0%) | -$35.20 K(-113.1%) |
| Sep 2022 | - | -$7900.00(-101.4%) | $268.00 K(+306.7%) |
| Jun 2022 | - | $550.00 K(-300.7%) | $65.90 K(-113.7%) |
| Mar 2022 | - | -$274.10 K(<-9900.0%) | -$482.30 K(+131.7%) |
| Dec 2021 | -$208.20 K(-103.9%) | $0.00(-100.0%) | -$208.20 K(+0.7%) |
| Sep 2021 | - | -$210.00 K(<-9900.0%) | -$206.80 K(-1353.3%) |
| Jun 2021 | - | $1800.00(>+9900.0%) | $16.50 K(-54.5%) |
| Mar 2021 | - | $0.00(-100.0%) | $36.30 K(-99.3%) |
| Dec 2020 | $5.30 M(+141.7%) | $1400.00(-89.5%) | $5.30 M(+4.4%) |
| Sep 2020 | - | $13.30 K(-38.4%) | $5.08 M(-32.1%) |
| Jun 2020 | - | $21.60 K(-99.6%) | $7.48 M(+0.3%) |
| Mar 2020 | - | $5.26 M(-2464.7%) | $7.46 M(+240.1%) |
| Dec 2019 | $2.19 M(+223.6%) | -$222.60 K(-109.2%) | $2.19 M(-24.8%) |
| Sep 2019 | - | $2.42 M(>+9900.0%) | $2.92 M(+264.3%) |
| Jun 2019 | - | $0.00(-100.0%) | $800.20 K(+8.4%) |
| Mar 2019 | - | $200.00(-100.0%) | $738.50 K(+9.0%) |
| Dec 2018 | $677.50 K(<-9900.0%) | $500.00 K(+66.7%) | $677.60 K(+402.3%) |
| Sep 2018 | - | $300.00 K(-586.2%) | $134.90 K(-163.7%) |
| Jun 2018 | - | -$61.70 K(+1.6%) | -$211.70 K(-20.6%) |
| Mar 2018 | - | -$60.70 K(+42.2%) | -$266.70 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$2400.00(-100.2%) | -$42.70 K(-8.4%) | -$2400.00(-100.6%) |
| Sep 2017 | - | -$46.60 K(-60.1%) | $420.20 K(-55.9%) |
| Jun 2017 | - | -$116.70 K(-157.3%) | $953.30 K(-30.7%) |
| Mar 2017 | - | $203.60 K(-46.4%) | $1.38 M(+17.4%) |
| Dec 2016 | $1.17 M(-13.7%) | $379.90 K(-21.9%) | $1.17 M(-32.8%) |
| Sep 2016 | - | $486.50 K(+59.5%) | $1.74 M(+38.7%) |
| Jun 2016 | - | $305.00 K(>+9900.0%) | $1.26 M(-7.4%) |
| Mar 2016 | - | $0.00(-100.0%) | $1.36 M(0.0%) |
| Dec 2015 | $1.36 M(-19.5%) | $951.70 K(>+9900.0%) | $1.36 M(+12.6%) |
| Sep 2015 | - | $0.00(-100.0%) | $1.21 M(-28.8%) |
| Jun 2015 | - | $405.00 K(>+9900.0%) | $1.69 M(+20.0%) |
| Mar 2015 | - | $0.00(-100.0%) | $1.41 M(-16.3%) |
| Dec 2014 | $1.69 M(+80.0%) | $800.00 K(+64.2%) | $1.69 M(+90.3%) |
| Sep 2014 | - | $487.30 K(+295.5%) | $885.90 K(+122.3%) |
| Jun 2014 | - | $123.20 K(-55.3%) | $398.60 K(+44.7%) |
| Mar 2014 | - | $275.40 K(>+9900.0%) | $275.40 K(-99.0%) |
| Dec 2013 | $936.50 K(-96.5%) | - | - |
| Sep 2009 | - | $1500.00(+650.0%) | $27.07 M(+0.0%) |
| Jun 2009 | - | $200.00(-98.0%) | $27.07 M(-0.1%) |
| Mar 2009 | - | $9900.00(-100.0%) | $27.09 M(+0.0%) |
| Dec 2008 | $27.08 M(>+9900.0%) | $27.06 M(>+9900.0%) | $27.08 M(>+9900.0%) |
| Sep 2008 | - | $0.00(-100.0%) | $19.30 K(-19.6%) |
| Jun 2008 | - | $19.30 K(>+9900.0%) | $24.00 K(+410.6%) |
| Mar 2008 | - | $0.00(0.0%) | $4700.00(0.0%) |
| Dec 2007 | $4700.00(-71.7%) | $0.00(-100.0%) | $4700.00(0.0%) |
| Sep 2007 | - | $4700.00(>+9900.0%) | $4700.00(>+9900.0%) |
| Jun 2007 | - | $0.00 | $0.00 |
| Dec 2006 | $16.60 K | - | - |
FAQ
- What is TRxADE HEALTH annual cash flow from financing activities?
- What is the all time high annual CFF for TRxADE HEALTH?
- What is TRxADE HEALTH annual CFF year-on-year change?
- What is TRxADE HEALTH quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for TRxADE HEALTH?
- What is TRxADE HEALTH quarterly CFF year-on-year change?
- What is TRxADE HEALTH TTM cash flow from financing activities?
- What is the all time high TTM CFF for TRxADE HEALTH?
- What is TRxADE HEALTH TTM CFF year-on-year change?
What is TRxADE HEALTH annual cash flow from financing activities?
The current annual CFF of MEDS is $1.41 M
What is the all time high annual CFF for TRxADE HEALTH?
TRxADE HEALTH all-time high annual cash flow from financing activities is $27.08 M
What is TRxADE HEALTH annual CFF year-on-year change?
Over the past year, MEDS annual cash flow from financing activities has changed by +$1.44 M (+4095.17%)
What is TRxADE HEALTH quarterly cash flow from financing activities?
The current quarterly CFF of MEDS is -$1.87 M
What is the all time high quarterly CFF for TRxADE HEALTH?
TRxADE HEALTH all-time high quarterly cash flow from financing activities is $27.06 M
What is TRxADE HEALTH quarterly CFF year-on-year change?
Over the past year, MEDS quarterly cash flow from financing activities has changed by +$12.02 M (+86.52%)
What is TRxADE HEALTH TTM cash flow from financing activities?
The current TTM CFF of MEDS is -$14.43 M
What is the all time high TTM CFF for TRxADE HEALTH?
TRxADE HEALTH all-time high TTM cash flow from financing activities is $27.09 M
What is TRxADE HEALTH TTM CFF year-on-year change?
Over the past year, MEDS TTM cash flow from financing activities has changed by -$1.26 M (-9.59%)